Mursla Bio

Mursla Bio is a pioneering biotech company on a mission to transform cancer care by pushing the boundaries of biopsy technology. Their initial focus is to transform the surveillance of liver cancer in high-risk populations. Mursla Bio's Dynamic Biopsy platform is non-invasive and provides a dynamic view of the biological processes within a specific organ or tissue. This approach combines the high accuracy and disease sub-typing precision of tissue biopsies with the simplicity of liquid biopsy sample collection.